Journals / Meme Sağlığı Dergisi / 2011 / Cilt: 7 - Sayı: 2

Risk factors in breast cancer, risk assessment and prevention: 2010 Istanbul consensus meeeting report

Meme kanserinde risk faktörleri, riskin değerlendirilmesi ve prevansiyon: İstanbul 2010 konsensus raporu

Pages
47–67
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Risk reduction surgery is another option for high risk patients and should be considered after multidisiplinary consultations.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Breast cancer is the most common female cancer and the second most common cause of cancer death in women.
📊
Key Findings & Data:These can be grouped into categories including factors related to demographics (eg, age, ethnicity/race); reproductive history (age at menarche, parity, age at first live birth, age at menopause); familial/genetic factors (family history, known or suspected BRCA 1/2, p53, PTEN or other gene mutation associated with breast cancer risk); environmental factors (prior thoracic irradiation before age 30 [eg, to treat Hodgkin’s disease], hormone replacement therapy, alcohol consumption); and other factors (eg, number of breast biopsies, atypical hyperplasia or lobular carcinoma in situ [LCIS], breast density, body mass index [BMI]).
💡
Conclusion & Impact:Risk reduction surgery is another option for high risk patients and should be considered after multidisiplinary consultations.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Breast cancer is the most common female cancer and the second most common cause of cancer death in women. Many risk factors have been associated with breast cancer. These can be grouped into categories including factors related to demographics (eg, age, ethnicity/race); reproductive history (age at menarche, parity, age at first live birth, age at menopause); familial/genetic factors (family history, known or suspected BRCA 1/2, p53, PTEN or other gene mutation associated with breast cancer risk); environmental factors (prior thoracic irradiation before age 30 [eg, to treat Hodgkin’s disease], hormone replacement therapy, alcohol consumption); and other factors (eg, number of breast biopsies, atypical hyperplasia or lobular carcinoma in situ [LCIS], breast density, body mass index [BMI]). Estimating breast cancer risk for the individual women is difficult. The development of effective strategies for the reduction of breast cancer incidence has also been difficult because of the few of the existing risk factors are modifiable. A number of lifestyle changes may reduce breast cancer risk. Even if breast cancer incidence cannot be substantially reduced for some women who are at high risk for developing the disease, the risk of death from breast cancer can be reduced by regular mammography screening. For women who are already at higher than average risk, their risk of developing breast cancer can be reduced by at least 50 percent or more by taking tamoxifen or raloxifene for five years. Risk reduction surgery is another option for high risk patients and should be considered after multidisiplinary consultations.

Özet

Meme kanseri kadınlarda görülen en sık kanser tipidir ve kadınlarda ölüme neden olan kanserler arasında da 2. sırada gelir. Meme kanseri ile ilişkili birçok risk faktörü tanımlanmıştır. Bu risk faktörleri demografik (yaş, etnisite/ırk), reprodüktif öykü (menarş yaşı, parite, ilk canlı doğum yaşı, menapoz yaşı), ailesel/genetik faktörler (aile öyküsü, meme kanseri riski ile ilişkili olduğu bilinen veya şüphe edilen BRCA 1/2, p53, PTEN veya diğer gen mutasyonları), çevresel faktörler (30 yaşından önce toraks bölgesine radyoterapi [örneğin Hodgkin hastalığı tedavisi nedeniyle], hormon replasman tedavisi, alkol kullanımı) ve diğer faktörler (meme biyopsi sayısı, atipik hiperplazi veya lobular karsinoma in situ [LCIS], dens meme yapısı, vücut kitle indeksi [BMI]) olarak sınıflandırılabilir. Her kadının meme kanseri riskini tahmin etmek zordur. Mevcut risk faktörlerinden çok az bir bölümü modifiye edilebilir özellikte olduğu için meme kanseri insidansını azaltmaya yönelik etkili stratejilerin geliştirilmesi oldukça güçtür. Yaşam tarzında yapılacak bazı değişiklikler meme kanseri riskinde azalmaya neden olabilir. Düzenli mamografi çekilmesi ile meme kanseri gelişimi açısından yüksek risk grubundaki bazı kadınlarda anlamlı bir risk azalması sağlanamasa bile, meme kanserine bağlı ölümlerde azalma elde edilecektir. Yüksek riskli kadınlarda 5 yıl süreyle tamoksifen veya raloksifen kullanılması meme kanseri riskinde yaklaşık %50 azalma sağlayacaktır. Risk azaltıcı cerrahi yüksek riskli kadınlar için bir diğer alternatifi oluşturmaktadır ve ancak multidisipliner konsültasyonlar yapıldıktan sonra düşünülmelidir.

🔖

Cite This Article

KOÇAK, Ş., ÇELİK, L., ÖZBAŞ, S., SAKA, D. S., TÜKÜN, A., Yalçın, B. (2011). Risk factors in breast cancer, risk assessment and prevention: 2010 Istanbul consensus meeeting report. Meme Sağlığı Dergisi, Cilt: 7 - Sayı: 2, 47–67. https://ajindex.com/articles/278114

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics 2009. CA Cancer J Clin 2009; 59: 225-249
  2. Tuncer M. Significance of cancer in Turkey, the burden of disease and cancer control policies (Volume 74). In: Tuncer M., eds. Cancer Control in Turkey, Ankara, Onur Press, Health Ministry Publication, 2008: 5-9
  3. NCCN Clinical Practice Guidelines in Oncology. Breast Cancer, 2009
  4. Özmen V, Fidaner C, Aksaz E, ve ark. Meme Sağlığı Dergisi, 2009; 5: 125-134
  5. Hsieh CC, Trichopoulos D, Katsouyanni K, Yuasa S. Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: associations and interactions in an international case-control study. Int J Cancer 1990; 46: 796-800
  6. Colditz GA, Rosner B. Cumulative risk of breast cancer to age 70 years according to risk factor status: data from the Nurses’ Health Study. Am J Epidemiol 2000; 152:950-964
  7. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet 1997; 350: 1047
  8. Rosner B, Colditz GA, Willett WC. Reproductive risk factors in a prospective study of breast cancer: The Nurses’ Health Study. Am J Epidemiol 1994; 139: 819-835
  9. Rossing MA, Daling JR, Weiss NS, Moore DE, Self SG. Risk of breast cancer in a cohort of infertile women. Gynecol Oncol 1996; 60: 3-7
  10. Modan B, Ron E, Lerner-Geva L, Blumstein T, Menczer J, Rabinovici J, Oelsner G, Freedman L, Mashiach S, Lunenfeld B. Cancer incidence in a cohort of infertile women. Am J Epidemiol 1998; 147: 1038-1042
  11. Beral V, Bull D, Doll R, Peto R, Reeves G; Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83,000 women with breast cancer from 16 countries. Lancet 2004; 363: 1007-1016
  12. Melbye M, Wohlfahrt J, Olsen JH, Frisch M, Westergaard T, Helweg- Larsen K, Andersen PK. Induced abortion and the risk of breast cancer. N Engl J Med 1997; 336: 81-85
  13. Erlandsson G, Montgomery SM, Cnattingius S, Ekbom A. Abortions and breast cancer: record-based case-control study. Int J Cancer 2003; 103: 676-679
  14. Paoletti X, Clavel-Chapelon F. Induced and spontaneous abortion and breast cancer risk: results from the E3N cohort study. Int J Cancer 2003; 106: 270-276
  15. Reeves GK, Kan SW, Key T, Tjønneland A,